Silence Therapeutics PLC
NASDAQ:SLN

Watchlist Manager
Silence Therapeutics PLC Logo
Silence Therapeutics PLC
NASDAQ:SLN
Watchlist
Price: 16.21 USD -7.58% Market Closed
Market Cap: 756.4m USD
Have any thoughts about
Silence Therapeutics PLC?
Write Note

Wall Street
Price Targets

SLN Price Targets Summary
Silence Therapeutics PLC

There are no price targets for SLN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available

SLN Last Price Targets
Silence Therapeutics PLC

The latest public price target was made on Jun 28, 2024 by Keay Nakae from Chardan Capital , who expects SLN stock to rise by 239% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Keay Nakae
Chardan Capital
55 USD
Upside 239%
4 months ago
Jun 28, 2024
Silence Therapeutics price target raised to $55 from $42 at Chardan
TheFly
Michael Ulz
Morgan Stanley
49 USD
Upside 202%
4 months ago
Jun 28, 2024
Silence Therapeutics price target raised to $49 from $45 at Morgan Stanley
TheFly
Kostas Biliouris
BMO Capital
67 USD
Upside 313%
8 months ago
Mar 13, 2024
BMO Capital Reiterates Silence Therapeutics (SLN) as Top Pick, 'buy the dip'
StreetInsider
Unknown Analyst
Morgan Stanley
18 USD
Upside 11%
1 year ago
Dec 9, 2022
Morgan Stanley Initiates Coverage On Silence Therapeutics with Equal-Weight Rating, Announces Price Target of $18
Benzinga
Unknown Analyst
Chardan Capital
29 USD
Upside 79%
1 year ago
Nov 17, 2022
Chardan Capital Maintains Buy on Silence Therapeutics, Lowers Price Target to $29
Benzinga
Keay Nakae
Chardan Capital
Price Target 55 USD
Upside/Downside 239%
View Source
Michael Ulz
Morgan Stanley
Price Target 49 USD
Upside/Downside 202%
View Source
Kostas Biliouris
BMO Capital
Price Target 67 USD
Upside/Downside 313%
View Source
Unknown Analyst
Morgan Stanley
Price Target 18 USD
Upside/Downside 11%
View Source
Unknown Analyst
Chardan Capital
Price Target 29 USD
Upside/Downside 79%
View Source
Silence Therapeutics PLC Competitors:
Price Targets
PBYI
Puma Biotechnology Inc
38% Upside
CAPR
Capricor Therapeutics Inc
116% Upside
CGON
CG Oncology Inc
87% Upside
GILD
Gilead Sciences Inc
6% Downside
300601
Shenzhen Kangtai Biological Products Co Ltd
0% Downside
2696
Shanghai Henlius Biotech Inc
12% Upside
ARGX
argenx SE
5% Downside
RPTX
Repare Therapeutics Inc
300% Upside

Revenue
Forecast

Revenue Estimate
Silence Therapeutics PLC

Revenue forecast
is not available for
Silence Therapeutics PLC

Operating Income
Forecast

Operating Income Estimate
Silence Therapeutics PLC

Operating Income forecast
is not available for
Silence Therapeutics PLC

Net Income
Forecast

Net Income Estimate
Silence Therapeutics PLC

Net Income forecast
is not available for
Silence Therapeutics PLC

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SLN's stock price target?
Not Available

SLN doesn't have any price targets made by Wall Street professionals.

Back to Top